OnabotulinumtoxinA in the Management of Psychogenic Dystonia
Phase of Trial: Phase IV
Latest Information Update: 31 May 2016
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Dystonia
- Focus Therapeutic Use
- 19 May 2016 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 19 May 2016 Status changed from not yet recruiting to recruiting.
- 04 Dec 2015 New trial record